Dauntless pharmaceuticals
WebAge : 67 Linked companies : Galera Therapeutics, Inc. Summary Michael F. Powell is a businessperson who founded Dauntless Pharmaceuticals, Inc. and who has been the head of 6 different companies. WebJul 22, 2015 · Dauntless Pharmaceuticals Inc. - Company Profiles - BCIQ For the biopharma industry investment, business development and competitive intelligence …
Dauntless pharmaceuticals
Did you know?
WebJul 21, 2015 · www.dauntlessph.com Ownership Status Privately Held (backing) Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries … WebDauntless Pharmaceuticals, Inc.'s headquarters is located at 9920 Pacific Heights Blvd Ste 150 San Diego, CA, 92121-4361 United States. What is Dauntless …
WebDec 13, 2024 · Furthermore, Dauntless Pharmaceuticals is developing DP1038, an intranasal octreotide, and is currently under clinical development. Existence of different online portals providing related... WebMar 17, 2024 · New Jersey, United States,- The research report focuses on target audiences of clients to help players to market their products effectively and achieve strong sales in the Neuroendocrine Tumor Treatment Market.It separates useful and relevant market information based on the business needs of the players. Readers are provided …
WebMay 4, 2024 · About Dauntless Pharmaceuticals, Inc. Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. Dauntless 1, its first asset company, was formed to develop DP1038, a therapeutic agent for the treatment of acromegaly and …
WebDauntless Pharmaceuticals, Inc. is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Biotechnology areas. …
WebWho is Dauntless Pharmaceuticals Headquarters 9920 Pacific Heights Blvd Ste 150, San Diego, California, 92121, United States Phone Number (858) 999-3053 Website … dacia keyless entry coverWebOct 6, 2024 · Most recently, Dr. Martin was the President and CEO of Dauntless Pharmaceuticals, a company that developed novel intranasal and injectable formulations of octreotide for acromegaly. Dr. Martin earned his Ph.D. in physical chemistry from UCSD and holds MBA and B.S. Chem. Honors degrees from the University of Michigan, Ann Arbor. binloo xl-011 stopwatchWebJan 25, 2024 · Dauntless Pharmaceuticals: ClinicalTrials.gov Identifier: NCT03031535 Other Study ID Numbers: DP1038-PK-101 : First Posted: January 25, 2024 Key Record … dacia leasing gewerblichWebJul 25, 2024 · Originator Dauntless Pharmaceuticals Class Antidiarrhoeals; Antineoplastics; Antisecretories; Cyclic peptides; Eye disorder therapies; Indoles; … bin lol playerWebJul 24, 2015 · Dauntless Pharmaceuticals, Inc. has announced the closing of a $12 million Series A financing. The Company was started by Joel F. Martin, PhD, Co-Founder, … dacia jogger recall whyWebJan 30, 2024 · Dauntless 1, its first asset company, was formed to develop DP1038, a therapeutic agent for the treatment of acromegaly and neuroendocrine tumors. Launched … dacia jogger wireless carplayWebBefore Statera, Dawn worked in multiple Clinical Operations roles of increased responsibility at Supernus Pharmaceuticals, Inc. where she developed a team of over 45 Clinical … dacia leather